Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03406208 · ClinicalTrials.gov registry record · NA
Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 228
- Enrollment target
NCT03406208: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03406208 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 228 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03406208, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 228 participants
- Enrollment target
Study Summary
The aims of this study are to compare the effect and durability of two stress and symptom management programs tailored for patients with neurofibromatosis on quality of life and psychosocial functioning.
Interventions
- BEHAVIORAL Stress and Symptom Management Program 1
- BEHAVIORAL Stress and Symptom Management Program 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2022-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03406208
The ClinicalTrials.gov registry entry for NCT03406208 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stress and Symptom Management Program 1 is the first listed.
NCT03406208 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03406208 about?
NCT03406208 is a clinical study titled "Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing". The aims of this study are to compare the effect and durability of two stress and symptom management programs tailored for patients with neurofibromatosis on quality of life and psychosocial functioning.
What is the current status of trial NCT03406208?
This trial is currently completed. It is a NA study. The enrollment target is 228 participants. The study started on 2017-10-01. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT03406208?
The interventions under investigation include: Stress and Symptom Management Program 1 (BEHAVIORAL), Stress and Symptom Management Program 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT03406208?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.